From theory to practice, implementing and executing, even the best supply chain strategy, often times leads to a retrospective of “what could we do better next time?” Join us to learn and discuss how the new era of system supported clinical supply chain data analytics can help move from local, incremental improvements to a global investing strategy and bring your life changing and saving therapies to both patients and the market faster.
Making improvements to your global clinical supply chain process takes time and money, making it all the more crucial to identify the actions that will make the best use of your resources. Having an end-to-end view of your clinical supply chain is fundamental to understanding not only how to invest but when and why. Addressing the most obvious bottlenecks does not necessarily bring the most value to the entire process. Simulating real-life investment scenarios, using clinical supply chain optimization software, will allow you to assess their return on investment at the sponsor level.
For example, did you know simulating your drug substance forecast and manufactured lot sizes across all compounds in your portfolio can take your clinical supply chain to the next level?
Sébastien Coppe, Life Sciences Director, N-SIDE
Sebastien Coppe has a Master of Engineering in Applied Mathematics. He obtained his PhD by creating a pre-diagnostic tool for patients suffering from Alzheimer’s disease and other kinds of dementia, by designing some mathematical modelling of the patients’ brain behaviour.
He is working at N-SIDE where he has been leading the Life Sciences activities for multiple years, providing services to more than 30 pharmaceutical companies in order to optimize their clinical trial designs and supplies thanks to forecasting and risk-based optimization solutions.
Cyrille Lefevre, Senior Expert, N-SIDE
Cyrille Lefevre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 7 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Lefevre also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.Message Presenter
Who Should Attend?
This webinar will appeal to managers or directors of:
- Clinical supply
- Clinical operations
- Clinical outsourcing
- Program management
- Clinical supply planning
What You Will Learn
Participants will learn:
- How identifying global, strategic investments unblocks clinical supply chain bottlenecks
- How applying clinical supply data analytics can help bring therapies to patients and to the market faster
- Lot sizing can save more than you think
- If your CMO contracts are facilitating or hindering your end-to-end clinical supply chain
- How to balance department-specific investment strategy with a more sponsor-level approach
N-SIDE, an innovative software consulting company, has been an active player in clinical trial supply chain management for almost 20 years. Using cloud-based cutting-edge technologies, their solutions optimize the entire clinical trial supply chain management process from planning and production through to protocol design and delivery of supplies. The N-SIDE Suite for Clinical Trials enables the pharmaceutical and biotech industry to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk.